Page last updated: 2024-09-04

cryptotanshinone and Cardiovascular Diseases

cryptotanshinone has been researched along with Cardiovascular Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
He, W; Liu, T; Luo, F; Shi, G; Wu, Y; Zhang, H; Zhang, L; Zhang, Y1

Other Studies

1 other study(ies) available for cryptotanshinone and Cardiovascular Diseases

ArticleYear
Cryptotanshinone ameliorates cardiac injury and cardiomyocyte apoptosis in rats with coronary microembolization.
    Drug development research, 2021, Volume: 82, Issue:4

    Topics: Administration, Oral; Animals; Apoptosis; Cardiovascular Diseases; Disease Models, Animal; Embolism; Male; Myocytes, Cardiac; NF-kappa B; Oxidative Stress; Phenanthrenes; Rats; Rats, Sprague-Dawley; Signal Transduction

2021